103 related articles for article (PubMed ID: 20110138)
1. A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studies.
Tsai KC; Chen YC; Hsiao NW; Wang CL; Lin CL; Lee YC; Li M; Wang B
Eur J Med Chem; 2010 Apr; 45(4):1544-51. PubMed ID: 20110138
[TBL] [Abstract][Full Text] [Related]
2. The effect of different electrostatic potentials on docking accuracy: a case study using DOCK5.4.
Tsai KC; Wang SH; Hsiao NW; Li M; Wang B
Bioorg Med Chem Lett; 2008 Jun; 18(12):3509-12. PubMed ID: 18502122
[TBL] [Abstract][Full Text] [Related]
3. Partial charge calculation method affects CoMFA QSAR prediction accuracy.
Mittal RR; Harris L; McKinnon RA; Sorich MJ
J Chem Inf Model; 2009 Mar; 49(3):704-9. PubMed ID: 19239274
[TBL] [Abstract][Full Text] [Related]
4. How to improve docking accuracy of AutoDock4.2: a case study using different electrostatic potentials.
Hou X; Du J; Zhang J; Du L; Fang H; Li M
J Chem Inf Model; 2013 Jan; 53(1):188-200. PubMed ID: 23244516
[TBL] [Abstract][Full Text] [Related]
5. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
6. CoMFA modeling of human catechol O-methyltransferase enzyme kinetics.
Sipilä J; Taskinen J
J Chem Inf Comput Sci; 2004; 44(1):97-104. PubMed ID: 14741015
[TBL] [Abstract][Full Text] [Related]
7. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
[TBL] [Abstract][Full Text] [Related]
8. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
Pandey G; Saxena AK
J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
[TBL] [Abstract][Full Text] [Related]
9. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
10. The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA.
Choo HY; Choi S; Jung SH; Koh HY; Pae AN
Bioorg Med Chem; 2003 Oct; 11(21):4585-9. PubMed ID: 14527555
[TBL] [Abstract][Full Text] [Related]
11. CoMFA and CoMSIA studies on 5-hydroxyindole-3-carboxylate derivatives as 5-lipoxygenase inhibitors: generation of homology model and docking studies.
Aparoy P; Suresh GK; Kumar Reddy K; Reddanna P
Bioorg Med Chem Lett; 2011 Jan; 21(1):456-62. PubMed ID: 21084193
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR studies on the inhibitors of AP-1 and NF-kappaB mediated transcriptional activation.
Qin J; Liu H; Li J; Ren Y; Yao X; Liu M
Eur J Med Chem; 2009 Jul; 44(7):2888-95. PubMed ID: 19128859
[TBL] [Abstract][Full Text] [Related]
13. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
Akula N; Lecanu L; Greeson J; Papadopoulos V
Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
[TBL] [Abstract][Full Text] [Related]
14. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional quantitative structure: activity relationship studies on diverse structural classes of HIV-1 integrase inhibitors using CoMFA and CoMSIA.
Nunthaboot N; Tonmunphean S; Parasuk V; Wolschann P; Kokpol S
Eur J Med Chem; 2006 Dec; 41(12):1359-72. PubMed ID: 17002889
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitors.
Puntambekar DS; Giridhar R; Yadav MR
Acta Pharm; 2006 Jun; 56(2):157-74. PubMed ID: 16613723
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional quantitative structure-activity relationship study for phenylsulfonyl carboxylates using CoMFA and CoMSIA.
Liu X; Yang Z; Wang L
Chemosphere; 2003 Dec; 53(8):945-52. PubMed ID: 14505717
[TBL] [Abstract][Full Text] [Related]
18. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional quantitative structure activity relationship (3D-QSAR) analysis for in vitro toxicity of chlorophenols to HepG2 cells.
Liu Y; Chen JN; Zhao JS; Yu HX; Wang XD; Jiang J; Jin HJ; Zhang JF; Wang LS
Chemosphere; 2005 Aug; 60(6):791-5. PubMed ID: 15946721
[TBL] [Abstract][Full Text] [Related]
20. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
Doddareddy MR; Cho YS; Koh HY; Pae AN
Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
